Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
ATM 信号通路中新型蛋白磷酸酶的鉴定
基本信息
- 批准号:7941711
- 负责人:
- 金额:$ 2.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2010-12-05
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisBiochemicalCell AgingCell Cycle ArrestCellsCellular AssayDNA DamageDNA RepairExpression LibraryGoalsHumanMediatingOncogenicPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPlayProtein Serine/Threonine PhosphataseProtein p53Protein phosphataseProteinsRegulationResearch Project GrantsRoleSignal PathwayStressTP53 geneTestingataxia telangiectasia mutated proteininorganic phosphatenovelpublic health relevancerepairedresponse
项目摘要
DESCRIPTION (provided by applicant): Upon DNA damage stress, the ATM kinase is rapidly phosphorylated and activated, which stimulates cell cycle arrest, cellular senescence, DNA repair, and apoptosis. When the cell is returning to its normal state following DNA repair, the ATM signaling pathway needs to be simultaneously inhibited. Very little is known about how the DNA damage response is 'deactivated' following repair. Recent evidence suggests that protein phosphatases contribute to closing the activation loop initiated by the ATM/ATR kinases to provide a homeostatic regulation. Our preliminary results showed that wildtype p53-induced phosphatase 1 (Wip1) inhibits ATM-p53 pathway by dephosphorylating several ATM targeted proteins. In particular, Wip1 stabilizes Mdm2 and MdmX by dephosphorylating their ATM phosphorylation site, resulting in decreased levels and activity of p53. If aberrantly regulated, Wip1 becomes an oncogenic phosphatase that inhibits the DNA damage response and p53 tumor suppressor pathways. We generated an expression library of human serine/threonine protein phosphatases, from which several novel phosphatases were identified as potential modulators in the ATM-p53 pathway. The hypothesis to be tested is that Wip1 and other inhibitory protein phosphatases may suppress DNA damage-induced p53 activity primarily through dephosphorylating and stabilizing Mdm2 and MdmX.
PUBLIC HEALTH RELEVANCE: Protein phosphatases remove phosphate from proteins and deactivate them, which may provide a homeostatic regulation in the DNA damage response pathway. The goal of this research project is to (1) clarify the functions of protein phosphatases in the ATM (Ataxia Telangiectasia Mutated) initiated DNA damage response pathway; (2) determine how protein phosphatases regulate DNA damage-induced p53 activity.
描述(由申请人提供):当DNA损伤应激时,ATM激酶迅速磷酸化并被激活,从而刺激细胞周期阻滞、细胞衰老、DNA修复和凋亡。当细胞在DNA修复后恢复正常状态时,ATM信号通路需要同时被抑制。我们对修复后DNA损伤反应如何“失活”知之甚少。最近的证据表明,蛋白磷酸酶有助于关闭由ATM/ATR激酶启动的激活环,以提供稳态调节。我们的初步结果表明,野生型p53诱导的磷酸酶1 (Wip1)通过使几个ATM靶向蛋白去磷酸化来抑制ATM-p53通路。特别是,Wip1通过去磷酸化Mdm2和MdmX的ATM磷酸化位点来稳定它们,从而降低p53的水平和活性。如果受到异常调控,Wip1会成为一种致癌磷酸酶,抑制DNA损伤反应和p53肿瘤抑制途径。我们建立了一个人类丝氨酸/苏氨酸蛋白磷酸酶的表达文库,从中确定了几个新的磷酸酶作为ATM-p53通路的潜在调节剂。待验证的假设是,Wip1和其他抑制性蛋白磷酸酶可能主要通过去磷酸化和稳定Mdm2和MdmX来抑制DNA损伤诱导的p53活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiongbin Lu其他文献
Xiongbin Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiongbin Lu', 18)}}的其他基金
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
靶向 FOXP3 mRNA 剪接用于乳腺癌免疫治疗
- 批准号:
10717185 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 2.59万 - 项目类别:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10545058 - 财政年份:2022
- 资助金额:
$ 2.59万 - 项目类别:
Identification of USP13 as a therapeutic target for ovarian cancer
鉴定 USP13 作为卵巢癌的治疗靶点
- 批准号:
10328885 - 财政年份:2018
- 资助金额:
$ 2.59万 - 项目类别:
Identification of USP13 as a therapeutic target for ovarian cancer
鉴定 USP13 作为卵巢癌的治疗靶点
- 批准号:
10092972 - 财政年份:2018
- 资助金额:
$ 2.59万 - 项目类别:
Targeting Human Cancers with Hemizygous Deletion of TP53
通过 TP53 半合子缺失靶向人类癌症
- 批准号:
9891965 - 财政年份:2017
- 资助金额:
$ 2.59万 - 项目类别:
Targeting HER2-low breast cancer with 17p loss
靶向 17p 缺失的 HER2 低乳腺癌
- 批准号:
10203209 - 财政年份:2016
- 资助金额:
$ 2.59万 - 项目类别:
Targeting HER2-low breast cancer with 17p loss
靶向 17p 缺失的 HER2 低乳腺癌
- 批准号:
10615742 - 财政年份:2016
- 资助金额:
$ 2.59万 - 项目类别:
Targeting HER2-low breast cancer with 17p loss
靶向 17p 缺失的 HER2 低乳腺癌
- 批准号:
10399601 - 财政年份:2016
- 资助金额:
$ 2.59万 - 项目类别:
Targeting Human Cancers with Hemizygous Deletion of TP53
通过 TP53 半合子缺失靶向人类癌症
- 批准号:
9074698 - 财政年份:2016
- 资助金额:
$ 2.59万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 2.59万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
EAGER: Elastic Electronics for Sensing Gut Luminal and Serosal Biochemical Release
EAGER:用于感测肠腔和浆膜生化释放的弹性电子器件
- 批准号:
2334134 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Standard Grant